The Wayback Machine - https://web.archive.org./web/20210829142301/https://ard.bmj.com/

Intro Pullout Text Widget

Annals of the Rheumatic Diseases (ARD)

is a leading rheumatology journal from BMJ and EULAR, publishing original research, reviews and recommendations

Impact Factor: 19.103
Citescore: 28.7
All metrics >>

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

ARD is an official journal of EULAR.

Free lay summaries are provided for selected research articles and all EULAR recommendations. You can keep up with the latest news via Twitter and Facebook.

Listen to the ARD podcast and subscribe in all podcast platforms, including Apple Podcast , Google Podcasts , Stitcher and Spotify.

Editor-in-Chief: Professor Josef Smolen, Medical University of Vienna, Austria
Editorial team

ARD is a Plan S compliant Transformative Journal.

COVID-19: a message from BMJ >>

Authors

Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Author information

Submit a paper

Free Lay Summaries

Are you looking for the latest rheumatology research findings presented in an easily accessible format to share with patients, carers or colleagues?

ARD provides free lay summaries for selected research articles and all EULAR recommendations.

These aim to clearly explain the results of the research studies as well as any implications for treatment of the specific condition. The summaries are written in plain language in a consistently structured format and checked for accuracy and readability by experts and patient representatives.

EULAR Recommendations

The EULAR Standing Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations is developed by a group of specialists in their field.

All EULAR recommendations are free to access.

Each recommendation also has an accompanying lay summary, which is also free to access.

EULAR Textbooks

Current Time 0:00

Duration Time 0:00

Loaded: 0%

Progress: 0%

Stream TypeLIVE

Remaining Time -0:00

EULAR textbooks

11 June, 2021

Learn more about the range of EULAR textbooks on rheumatology published by BMJ.

Twitter Feed

ARD & RMD Open @ARD_BMJ

#osteoarthritis patients with structural progression in the past are less likely to display further structural progression

patients with pain are more likely to have progressive pain

.
https://t.co/lCil4M6Ymo https://t.co/8LJ2rFFmNo

View on Twitter

ARD & RMD Open @ARD_BMJ

Additional evidence for changes in the gut #microbiome in patients with #lupus and overlap between biological pathways activated in the #SLE microbiome and by SLE genetic risk factors

!
https://t.co/1UG02W7KcV https://t.co/jHGfiwEe01

View on Twitter

ARD & RMD Open @ARD_BMJ

We are looking for the next Editor-in-Chief who can continue to shape RMD Open into the premier #openaccess journal for #rheumatology. Apply by: 31 Aug 2021 https://t.co/nLKIkvCG7b https://t.co/zP8OLzhI0i

View on Twitter

ARD & RMD Open @ARD_BMJ

Intensive treatments deliver good long-term results https://t.co/pAHaWAZH4Y

View on Twitter

ARD & RMD Open @ARD_BMJ

Rheumatologists, look out for FibroCOVID

up to 30% of patients with postacute #COVID-19 syndrome (PACS) meet #fibromyalgia criteria. Strongest risk factors are male gender and obesity.
https://t.co/3c7BwSN99V

View on Twitter

ARD & RMD Open @ARD_BMJ

Want ot improve quality of care for patients with early inflammatory #arthritis? These factors are key

Check out the whole study here https://t.co/eCkwsmkplm https://t.co/tztVjUTA8v

View on Twitter

Jobs

Locum Consultant in Rheumatology

Stevenage

£82,096 a year

This is a fixed-term appointment available from 15th October 2021 for 12 months to cover a period of maternity leave. This is an excellent opportuni..

Recruiter: East and North Hertfordshire NHS Trust

Consultant in Rheumatology and Acute Medicine

Hampstead Town, London (Greater)

£82,096 - £110,683

We are seeking an enthusiastic and innovative Consultant in Rheumatology & Acute Medicine at the Royal Free Hospital.

Recruiter: Royal Free London NHS Foundation Trust

Physician Associate - Rheumatology

St.Georges's NHS Foundation Trust, London

£47,154 - £52,936 Pa inc HCAS

Physician Associate posts are positions to support a team of consultants, junior doctors and nursing staff & therapists within each department.

Recruiter: St George's University Hospitals NHS Foundation Trust

Consultant, Senior Registrar & Registrar

Saudi Arabia (SA)

[object Object]

Consultant, Senior Registrar & Registrar required for various position in all specialties.

Recruiter: Shamco International

Consultant Rheumatologist

Gloucester

£82,096 to £110,683 a year

The Trust provides a comprehensive Rheumatology service in Gloucestershire. The services are currently led by five consultants who are employed by ...

Recruiter: Gloucestershire Hospitals NHS Foundation Trust

Jul	AUG	Oct
	29
2020	2021	2022

Intro Pullout Text Widget

Annals of the Rheumatic Diseases (ARD)

Authors

Free Lay Summaries

Latest COVID-19 Content - FREE

LETTER:

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

CORRESPONDENCE RESPONSE:

Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks

CORRESPONDENCE:

Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry” by Sparks

CORRESPONDENCE:

Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry” by Sparks

CORRESPONDENCE RESPONSE:

Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks

Latest Articles

Review:

Message from the new EULAR President and Steering Group

Letter:

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

Systemic lupus erythematosus:

Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese

Correspondence response:

Response to: Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis” by Sparks

Recommendation:

2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

Articles by Topic

View full list

EULAR Recommendations

EULAR Textbooks

EULAR textbooks

Twitter Feed

Jobs

Locum Consultant in Rheumatology

Consultant in Rheumatology and Acute Medicine

Physician Associate - Rheumatology

Consultant, Senior Registrar & Registrar

Consultant Rheumatologist